Consolidated statements of income and comprehensive income

Consolidated statements of income and comprehensive income

(unaudited)

Consolidated income statement

 

Nine months ended 30 September

(thousands of €, except share and per share data)

2017

2016

Revenues

87,870

50,009

Other income

18,484

15,031

Total revenues and other income

106,354

65,040

 

 

 

Research and development expenditure

(149,226)

(96,739)

General and administrative expenses

(17,783)

(15,511)

Sales and marketing expenses

(1,898)

(1,272)

Total operating expenses

(168,907)

(113,522)

 

 

 

Operating loss

(62,552)

(48,482)

 

 

 

Fair value re-measurement of share subscription agreement

57,479

Other financial income

3,663

2,642

Other financial expenses

(26,805)

(3,500)

 

 

 

Profit / loss (–) before tax

(85,694)

8,138

 

 

 

Income taxes

(161)

(71)

 

 

 

Net income / loss (–)

(85,855)

8,067

Net income / loss (–) attributable to:

 

 

Owners of the parent

(85,855)

8,067

Basic income / loss (–) per share

(1.75)

0.18

Diluted income / loss (–) per share

(1.75)

0.17

Weighted average number of shares – basic (in thousands of shares)

48,996

45,527

Weighted average number of shares – diluted (in thousands of shares)

48,996

47,054

Consolidated statements of comprehensive income

 

Nine months ended 30 September

(thousands of €)

2017

2016

Net income / loss (–)

(85,855)

8,067

Items that may be reclassified subsequently to profit or loss:

 

 

Fair value adjustment of available-for-sale financial assets

(62)

(122)

Translation differences, arisen from translating foreign activities

(569)

(816)

Other comprehensive income, net of income tax

(631)

(938)

 

 

 

Total comprehensive income attributable to:

 

 

Owners of the parent

(86,486)

7,129